Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland

Quality of vitamin K antagonist oral anticoagulation in 322 patients with atrial fibrillation – real-life data from a survey in Eastern Switzerland

AIM OF THE STUDY: To better appreciate the role of the non-vitamin K oral anticoagulants (NOACs) for patients with non-valvular atrial fibrillation in Switzerland we aimed to assess the quality of vitamin K antagonist (VKA) anticoagulation in daily practice. METHODS: In a cross-sectional...

Full description

Bibliographic Details
Main Authors: Micha T. Maeder, Tabea König, Sanja Bogdanovic, Irene Schneider, Werner Eugster, Peter Ammann, Marius König, Jürg H. Beer, Hans Rickli
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2017-10-01
Series:Swiss Medical Weekly
Subjects:
atrial fibrillation
INR
non-vitamin K antagonist oral anticoagulation
oral anticoagulation
time to therapeutic range
vitamin K antagonist
Online Access:https://www.smw.ch/index.php/smw/article/view/2368

Internet

https://www.smw.ch/index.php/smw/article/view/2368

Similar Items